+1 (202) 780-3397
2024: Volume 8, Issue 6
Commentary P.1-2
Understanding end-stage renal disease (esrd): Challenges, advances, and the path forward.
Author(s):
Junwei Ding*
DOI: DOI: 10.35841/aacnt-8.6.231
Opinion Article P.1-2
Exploring the complexities of mineral bone disorder (MBD): Pathophysiology, Diagnosis, and Therapeutic approaches.
Author(s):
Lucas Souto*
DOI: DOI: 10.35841/aacnt-8.6.232
Perspective P.1-2
Advancements and applications of nephrology biomarkers in clinical practice.
Author(s):
Morteza Wan*
DOI: DOI: 10.35841/aacnt-8.6.233
Rapid Communication P.1-1
Exploring cardiorenal syndrome: Understanding the interplay between heart and kidney dysfunction.
Author(s):
Suleyki Issac*
DOI: DOI: 10.35841/aacnt-8.6.234
Short Communication P.1-2
Understanding diabetic nephropathy: pathophysiology, diagnosis, and treatment approaches.
Author(s):
Pedro Teresa*
DOI: DOI: 10.35841/aacnt-8.6.235
Commentary P.1-2
The Role of Genomic Nephrology in Shaping the Future of Kidney Disease Diagnosis and Treatment.
Author(s):
Vanessa Wright*
DOI: DOI: 10.35841/aacnt-8.6.236
Opinion Article P.1-2
Advances in nephrolithiasis management: Strategies, challenges, and future directions.
Author(s):
Wing Lu*
DOI: DOI: 10.35841/aacnt-8.6.237
Perspective P.1-1
Advances in uremic toxins clearance: A comprehensive approach to enhancing renal health.
Author(s):
Gabriel Zand*
DOI: DOI: 10.35841/aacnt-8.6.238
Rapid Communication P.1-2
Advancements in proteinuria reduction strategies: A critical approach to kidney disease management.
Author(s):
Eran Peled*
DOI: DOI: 10.35841/aacnt-8.6.239
Short Communication P.1-2
Advancements in renal pharmacology: Shaping the future of kidney disease treatment.
Author(s):
Alaa Elrggal*
DOI: DOI: 10.35841/aacnt-8.6.240